inositol has been researched along with Fetal Growth Retardation in 13 studies
Inositol: An isomer of glucose that has traditionally been considered to be a B vitamin although it has an uncertain status as a vitamin and a deficiency syndrome has not been identified in man. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1379) Inositol phospholipids are important in signal transduction.
inositol : Any cyclohexane-1,2,3,4,5,6-hexol.
1D-chiro-inositol : Belonging to the inositol family of compounds, D-chiro-inositol (DCI) is an isomer of glucose. It is an important secondary messenger in insulin signal transduction.
muco-inositol : An inositol that is cyclohexane-1,2,3,4,5,6-hexol having a (1R,2R,3r,4R,5S,6r)-configuration.
Fetal Growth Retardation: Failure of a FETUS to attain expected GROWTH.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Myo-inositol treatment in early pregnancy is associated with a reduction in the rate of gestational diabetes mellitus and in the risk of preterm birth and macrosomia in women who are at risk for gestational diabetes mellitus." | 3.88 | Clinical and metabolic outcomes in pregnant women at risk for gestational diabetes mellitus supplemented with myo-inositol: a secondary analysis from 3 RCTs. ( Alibrandi, A; Corrado, F; D'Anna, R; Di Benedetto, A; Facchinetti, F; Pintaudi, B; Santamaria, A, 2018) |
| "Inositol is a cyclic sugar alcohol which occurs naturally in a variety of stereoisomers, the most common of which is myo-inositol." | 2.49 | Myoinositol: a new marker of intrauterine growth restriction? ( Dessì, A; Fanos, V, 2013) |
| "A total of 26 prematurely born intrauterine growth restriction infants (birthweight <10th centile for gestational age), 22 prematurely born but adequate for gestational age controls, and 26 term adequate-for-gestational-age infants underwent brain magnetic resonance imaging and magnetic resonance spectroscopy at 1 year of age during natural sleep, on a 3 Tesla scanner." | 1.46 | Brain metabolite alterations in infants born preterm with intrauterine growth restriction: association with structural changes and neurodevelopmental outcome. ( Bargalló, N; Cruz-Lemini, M; Eixarch, E; Gratacós, E; Muñoz-Moreno, E; Sanz-Cortés, M; Simões, RV, 2017) |
| "The subgroup with late intrauterine growth restriction further showed lower estimated glutathione levels at age 1 year." | 1.42 | Brain metabolite differences in one-year-old infants born small at term and association with neurodevelopmental outcome. ( Bargalló, N; Cruz-Lemini, M; Gratacós, E; Sanz-Cortés, M; Simões, RV, 2015) |
| "Myo-inositol (Myo-ins) is a marker of neuroglial cells, being present in the astrocytes of brain tissue, but also functions as an osmolyte." | 1.39 | Myo-inositol metabolism in appropriately grown and growth-restricted fetuses: a proton magnetic resonance spectroscopy study. ( Allsop, JM; Damodaram, MS; Kumar, S; Mcguinness, A; Patel, A; Rutherford, MA; Story, L; Supramaniam, V; Wylezinska, M, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.69) | 18.7374 |
| 1990's | 1 (7.69) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 11 (84.62) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Santamaria, A | 1 |
| Alibrandi, A | 1 |
| Di Benedetto, A | 1 |
| Pintaudi, B | 1 |
| Corrado, F | 1 |
| Facchinetti, F | 1 |
| D'Anna, R | 1 |
| Story, L | 1 |
| Damodaram, MS | 1 |
| Supramaniam, V | 1 |
| Allsop, JM | 1 |
| Mcguinness, A | 1 |
| Patel, A | 1 |
| Wylezinska, M | 1 |
| Kumar, S | 1 |
| Rutherford, MA | 1 |
| Dessì, A | 2 |
| Fanos, V | 2 |
| Metges, CC | 1 |
| Görs, S | 1 |
| Lang, IS | 1 |
| Hammon, HM | 1 |
| Brüssow, KP | 1 |
| Weitzel, JM | 1 |
| Nürnberg, G | 1 |
| Rehfeldt, C | 1 |
| Otten, W | 1 |
| Barberini, L | 1 |
| Noto, A | 1 |
| Fattuoni, C | 1 |
| Grapov, D | 1 |
| Casanova, A | 1 |
| Fenu, G | 1 |
| Gaviano, M | 1 |
| Carboni, R | 1 |
| Ottonello, G | 1 |
| Crisafulli, M | 1 |
| Simões, RV | 2 |
| Cruz-Lemini, M | 2 |
| Bargalló, N | 2 |
| Gratacós, E | 2 |
| Sanz-Cortés, M | 2 |
| Muñoz-Moreno, E | 1 |
| Eixarch, E | 1 |
| Regnault, TR | 1 |
| Teng, C | 1 |
| de Vrijer, B | 1 |
| Galan, HL | 2 |
| Wilkening, RB | 1 |
| Battaglia, FC | 2 |
| Nissen, PM | 1 |
| Nebel, C | 1 |
| Oksbjerg, N | 1 |
| Bertram, HC | 1 |
| Arroyo, JA | 1 |
| Garcia-Jones, P | 1 |
| Graham, A | 1 |
| Teng, CC | 1 |
| Berger-Kulemann, V | 1 |
| Brugger, PC | 1 |
| Pugash, D | 1 |
| Krssak, M | 1 |
| Weber, M | 1 |
| Wielandner, A | 1 |
| Prayer, D | 1 |
| Hallman, M | 1 |
| Wermer, D | 1 |
| Epstein, BL | 1 |
| Gluck, L | 1 |
| Cortey, A | 1 |
| Jarvik, JG | 1 |
| Lenkinski, RE | 1 |
| Grossman, RI | 1 |
| Frank, I | 1 |
| Delivoria-Papadopoulos, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Myoinositol Supplementation, Insulin Resistance and Fetal Sonographic Parameters in Gestational Diabetes, Diet Treated: a Prospective, Randomized, Placebo-controlled Study[NCT03763669] | 120 participants (Actual) | Interventional | 2018-11-14 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for inositol and Fetal Growth Retardation
| Article | Year |
|---|---|
Myoinositol: a new marker of intrauterine growth restriction?
Topics: Biomarkers; Female; Fetal Growth Retardation; Humans; Inositol; Pregnancy | 2013 |
12 other studies available for inositol and Fetal Growth Retardation
| Article | Year |
|---|---|
Clinical and metabolic outcomes in pregnant women at risk for gestational diabetes mellitus supplemented with myo-inositol: a secondary analysis from 3 RCTs.
Topics: Adult; Diabetes Mellitus, Type 2; Diabetes, Gestational; Dietary Supplements; Female; Fetal Growth R | 2018 |
Myo-inositol metabolism in appropriately grown and growth-restricted fetuses: a proton magnetic resonance spectroscopy study.
Topics: Astrocytes; Brain; Case-Control Studies; Creatine; Female; Fetal Growth Retardation; Fetus; Humans; | 2013 |
Low and high dietary protein:carbohydrate ratios during pregnancy affect materno-fetal glucose metabolism in pigs.
Topics: Adaptation, Physiological; Animals; Area Under Curve; Blood Glucose; Brain; Diet; Diet, Carbohydrate | 2014 |
Urinary metabolomics (GC-MS) reveals that low and high birth weight infants share elevated inositol concentrations at birth.
Topics: Biomarkers; Birth Weight; Female; Fetal Growth Retardation; Gas Chromatography-Mass Spectrometry; Ge | 2014 |
Brain metabolite differences in one-year-old infants born small at term and association with neurodevelopmental outcome.
Topics: Adaptation, Psychological; Aspartic Acid; Brain; Child Development; Child, Preschool; Cognition; Cre | 2015 |
Brain metabolite alterations in infants born preterm with intrauterine growth restriction: association with structural changes and neurodevelopmental outcome.
Topics: Adaptation, Psychological; Anisotropy; Aspartic Acid; Brain; Child, Preschool; Choline; Cognition; C | 2017 |
The tissue and plasma concentration of polyols and sugars in sheep intrauterine growth retardation.
Topics: Animals; Carbohydrate Metabolism; Carbohydrates; Female; Fetal Growth Retardation; Fetus; Fructose; | 2010 |
Metabolomics reveals relationship between plasma inositols and birth weight: possible markers for fetal programming of type 2 diabetes.
Topics: Animals; Biomarkers; Birth Weight; Diabetes Mellitus, Type 2; Female; Fetal Growth Retardation; Gas | 2011 |
Placental TonEBP/NFAT5 osmolyte regulation in an ovine model of intrauterine growth restriction.
Topics: Aldehyde Reductase; Animals; Female; Fetal Growth Retardation; Inositol; Models, Animal; NADP; NFATC | 2012 |
MR spectroscopy of the fetal brain: is it possible without sedation?
Topics: Aspartic Acid; Brain; Choline; Conscious Sedation; Creatine; Female; Fetal Diseases; Fetal Growth Re | 2013 |
Effects of maternal insulin or glucose infusion on the fetus: study on lung surfactant phospholipids, plasma myoinositol, and fetal growth in the rabbit.
Topics: Animals; Blood Glucose; Female; Fetal Growth Retardation; Fetal Organ Maturity; Fetus; Glucose; Infu | 1982 |
Proton MR spectroscopy of brain abnormalities in neonates born to HIV-positive mothers.
Topics: AIDS Dementia Complex; Aspartic Acid; Choline; Diagnosis, Differential; Energy Metabolism; Female; F | 1994 |